Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

ROSEN, A TOP RANKED LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXL

Newsfile April 1, 2022

Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit

GlobeNewswire March 28, 2022

Anavex Life Sciences Corp. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Newsfile March 21, 2022

Anavex Life Sciences Corp. Investigated by Block & Leviton for Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged To Contact the Firm

Newsfile March 16, 2022

ROSEN, A LEADING LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXL

PR Newswire March 15, 2022

Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from ANAVEX®2-73-PDD-001 Parkinson's Disease Dementia Study at AD/PD(TM) 2022 International Conference

GlobeNewswire March 15, 2022

Anavex Life Sciences to Participate in the Annual Needham Virtual Neuroscience Forum

GlobeNewswire March 9, 2022

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXL

PR Newswire March 7, 2022

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors

Business Wire March 7, 2022

The Law Offices of Frank R. Cruz Continues Its Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors

Business Wire March 7, 2022

Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP

GlobeNewswire March 4, 2022

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Anavex Life Sciences Corp. Investors with Losses to Inquire About Securities Class Action Investigation - AVXL

Newsfile February 22, 2022

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXL

PR Newswire February 18, 2022

ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation - AVXL

Newsfile February 16, 2022

Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire February 10, 2022

AVXL INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors with Losses to Inquire About Securities Class Action Investigation - AVXL

PR Newswire February 9, 2022

Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 First Quarter Financial Results

GlobeNewswire February 9, 2022

(AVXL) News: Did You Lose Money on Anavex Life Sciences Corp. Investment? Contact Johnson Fistel Regarding Class Action Investigation

Newsfile February 4, 2022

Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

Newsfile February 4, 2022

Anavex Life Sciences Provides Supplemental Information on ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial for the Treatment of Adult Patients with Rett Syndrome

GlobeNewswire February 4, 2022